Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis
暂无分享,去创建一个
[1] K. Kwon,et al. Clinical characteristics predicting early clinical failure after 72 h of antibiotic treatment in women with community-onset acute pyelonephritis: a prospective multicentre study. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[2] S. Geerlings,et al. Appropriate antibiotic use for patients with urinary tract infections reduces length of hospital stay. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] N. Woodford,et al. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? , 2013, The Journal of antimicrobial chemotherapy.
[4] Sudeep Singh,et al. Complicated urinary tract infections. , 2013, Journal of the Indian Medical Association.
[5] S. Wie,et al. Use of gentamicin for women with community-acquired uncomplicated acute pyelonephritis caused by gentamicin-susceptible or -resistant Escherichia coli: 10-year experience. , 2013, Microbial drug resistance.
[6] C. Sable,et al. Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study , 2012, Current medical research and opinion.
[7] Hyo Youl Kim,et al. Comparison of Ertapenem and Ceftriaxone Therapy for Acute Pyelonephritis and Other Complicated Urinary Tract Infections in Korean Adults: A Randomized, Double-Blind, Multicenter Trial , 2012, Journal of Korean medical science.
[8] Jieun Kim,et al. Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact. , 2012, Microbial drug resistance.
[9] W. Lee,et al. Change of Antimicrobial Susceptibility among Escherichia coli Strains Isolated from Female Patients with Community-Onset Acute Pyelonephritis , 2011, Yonsei medical journal.
[10] Richard Colgan,et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] L. Nicolle. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. , 2008, The Urologic clinics of North America.
[12] D. Paterson,et al. A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] K. Laupland,et al. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. , 2005, The Journal of antimicrobial chemotherapy.
[14] K. Ramakrishnan,et al. Diagnosis and management of acute pyelonephritis in adults. , 2005, American family physician.
[15] Henry D. Isenberg,et al. Clinical Microbiology Procedures Handbook , 2004 .
[16] K. Naber,et al. Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections. , 2002, International journal of antimicrobial agents.
[17] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[18] B. Walsh,et al. Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil. , 1989, The Journal of antimicrobial chemotherapy.
[19] S. Safrin,et al. Pyelonephritis in adult women: inpatient versus outpatient therapy. , 1988, The American journal of medicine.
[20] R. Sykes,et al. The sensitivity of urinary isolates to cefuroxime, a new beta-lactamase stable cephalosporin. , 1980, Current medical research and opinion.
[21] Ronald N. Jones,et al. Cefuroxime, a New Parenteral Cephalosporin: Collaborative In Vitro Susceptibility Comparison with Cephalothin Against 5,887 Clinical Bacterial Isolates , 1977, Antimicrobial Agents and Chemotherapy.
[22] C. O'callaghan,et al. Cefuroxime, a New Cephalosporin Antibiotic: Activity In Vitro , 1976, Antimicrobial Agents and Chemotherapy.